Showing 33,101 - 33,120 results of 102,654 for search '(( 50 ((nn decrease) OR (mean decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.18s Refine Results
  1. 33101

    Image_3_Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2.jpeg by Mariette Barbier (526468)

    Published 2022
    “…In addition, the cost of creating these therapeutic treatments is high, making their implementation in low- to middle-income countries devastated by the pandemic very difficult. Here, we explored the use of polyclonal EpF(ab’)<sub>2</sub> antibodies generated through the immunization of horses with SARS-CoV-2 WA-1 RBD conjugated to HBsAg nanoparticles as a low-cost therapeutic treatment for severe cases of disease. …”
  2. 33102

    Image_1_Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2.jpeg by Mariette Barbier (526468)

    Published 2022
    “…In addition, the cost of creating these therapeutic treatments is high, making their implementation in low- to middle-income countries devastated by the pandemic very difficult. Here, we explored the use of polyclonal EpF(ab’)<sub>2</sub> antibodies generated through the immunization of horses with SARS-CoV-2 WA-1 RBD conjugated to HBsAg nanoparticles as a low-cost therapeutic treatment for severe cases of disease. …”
  3. 33103

    Image_3_Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2.jpeg by Mariette Barbier (526468)

    Published 2022
    “…In addition, the cost of creating these therapeutic treatments is high, making their implementation in low- to middle-income countries devastated by the pandemic very difficult. Here, we explored the use of polyclonal EpF(ab’)<sub>2</sub> antibodies generated through the immunization of horses with SARS-CoV-2 WA-1 RBD conjugated to HBsAg nanoparticles as a low-cost therapeutic treatment for severe cases of disease. …”
  4. 33104

    Image_2_Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2.jpeg by Mariette Barbier (526468)

    Published 2022
    “…In addition, the cost of creating these therapeutic treatments is high, making their implementation in low- to middle-income countries devastated by the pandemic very difficult. Here, we explored the use of polyclonal EpF(ab’)<sub>2</sub> antibodies generated through the immunization of horses with SARS-CoV-2 WA-1 RBD conjugated to HBsAg nanoparticles as a low-cost therapeutic treatment for severe cases of disease. …”
  5. 33105

    Femtosecond laser-ablative aqueous synthesis of multi-drug antiviral nanoparticles by Rebecca R. Schmitt (20872565)

    Published 2025
    “…In this work, we introduce a multi-drug nanoparticle fabricated using femtosecond laser ablation for the treatment of influenza, SARS-CoV-2, and their co-infections.…”
  6. 33106
  7. 33107

    EP1 mediates pelvic pain. by Wenbin Yang (661259)

    Published 2020
    “…In contrast, mice treated with the EP1 antagonist ONO-8711 exhibited significantly decreased allodynia 1 h after treatment relative to baseline (Baseline<sub>ONO</sub>) (n = 5 mice, **P < 0.01, unpaired <i>t</i> test; see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0235384#pone.0235384.s001" target="_blank">S1 File</a>).…”
  8. 33108
  9. 33109
  10. 33110

    A mt-tRNA<sup>Ser(UCN)</sup> point mutation, m.7480A>G, impairs i<sup>6</sup>A37 modification. by John W. Yarham (573109)

    Published 2014
    “…<b>B</b>) The i<sup>6</sup>A modification of position 37 is decreased (stronger binding of the mt-tRNA<sup>Ser(UCN)</sup> double ACL probe) by ∼86% in patient skeletal muscle relative to control muscle. …”
  11. 33111
  12. 33112

    The ability of the bacterium Aminobacter MSH1 to establish in sand microcosms and degrade the pesticide-residue BAM when inoculated in concentrations of 10<sup>5</sup> cells L<sup>... by Flemming Ekelund (304569)

    Published 2015
    “…We fitted data to a simple bell-shaped Gaussian curve; y = a*exp(0.5*((x- d<sub>opt</sub>)/b)<sup>2</sup>), to test the underlying hypothesis that BAM-degradation would be most efficient at intermediate diversity-levels. …”
  13. 33113

    DataSheet_1_Extracellular vesicle-associated microRNA-30b-5p activates macrophages through the SIRT1/ NF-κB pathway in cell senescence.pdf by Yu Xiao (150812)

    Published 2022
    “…Significantly more EVs were found in the supernatant of SEN than of control (CON) cell cultures, and SEN EVs were enriched in miR-30b-5p, which directly target sirtuin1 (SIRT1). In vitro, we found that SEN EV treatment resulted in increased cellular levels of interleukin-1β (IL-1β) and IL-6 and decreased levels of SIRT1. …”
  14. 33114
  15. 33115
  16. 33116

    Nuclear Acss2 regulates <i>in vitro</i> tumor cell properties. by Rui Chen (95310)

    Published 2017
    “…Comparison of samples within a given condition on the day of interest was performed by two-way (cell proliferation) or one-way (colony formation, cell migration, cell invasion) ANOVA followed by Dunnett’s multiple comparisons test using control shRNA knockdown/control rescue as reference with decreased samples noted (*, P<0.05). …”
  17. 33117
  18. 33118

    Silencing of <i>MYCN</i> selectively alters genomic DNA binding of its cofactors. by Zhihui Liu (95891)

    Published 2024
    “…(<b>B</b>) Metagene plots show that the knockdown of <i>MYCN</i> results in a decrease of average MYCN and WDR5 ChIP-seq signal at the MYCN peak center of the MYCN and WDR5 overlapped binding sites. …”
  19. 33119

    Inhibitors targeting canonical and non-canonical TGFβ signaling show that SNC first targets TAK/p38 signaling and then indirectly Smad signaling. by Alison M. Heffer (7392503)

    Published 2019
    “…B) After 48 hours, cells treated with TGFβ in the presence of both SB-431542 and SNC showed decreased Smad signaling. C) TAK signaling was affected both after 1 hour (C) and 48 hours (D) in cells treated with either the TAK inhibitor (5Z)-7-oxozeaenol or SNC upon TGFβ stimulation. …”
  20. 33120

    Table_5_Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030.DOCX... by Qi Zeng (221318)

    Published 2023
    “…Period effect indicated that the RR of prevalence increased over time, whereas the RR of mortality and DALYs decreased in men but increased in women. The cohort effect exhibited that the more recent birth cohort had a higher RR than the previous cohort in prevalence. …”